Scientists recently unveiled a first-of-its-kind authentication protocol for wireless, battery-free, ultraminiaturized implants that ensures these devices remain protected while still allowing ...
Clinical Trials Arena on MSN1d
Omnipod 5 improves glycaemic levels in people transitioning from daily injectionsIndividuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...
Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...
Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...
Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
The Abington Community Library hosts the monthly Insulin Pump Support Group on the third Thursday of each month at 6 p.m. It ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback